Next Article in Journal
Next-Generation Sequencing: A Promising Tool for Vaccines and Other Biological Products
Next Article in Special Issue
A COVID-19 DNA Vaccine Candidate Elicits Broadly Neutralizing Antibodies against Multiple SARS-CoV-2 Variants including the Currently Circulating Omicron BA.5, BF.7, BQ.1 and XBB
Previous Article in Journal
Cell Surface Fibroblast Activation Protein-2 (Fap2) of Fusobacterium nucleatum as a Vaccine Candidate for Therapeutic Intervention of Human Colorectal Cancer: An Immunoinformatics Approach
Previous Article in Special Issue
Development of Bivalent mRNA Vaccines against SARS-CoV-2 Variants
 
 
Article

Article Versions Notes

Vaccines 2023, 11(3), 526; https://doi.org/10.3390/vaccines11030526
Action Date Notes Link
article xml file uploaded 23 February 2023 11:10 CET Original file -
article xml uploaded. 23 February 2023 11:10 CET Update https://www.mdpi.com/2076-393X/11/3/526/xml
article pdf uploaded. 23 February 2023 11:10 CET Version of Record https://www.mdpi.com/2076-393X/11/3/526/pdf
article supplementary file uploaded. 23 February 2023 11:10 CET - https://www.mdpi.com/2076-393X/11/3/526#supplementary
article html file updated 23 February 2023 11:11 CET Original file -
article html file updated 9 March 2023 22:20 CET Update https://www.mdpi.com/2076-393X/11/3/526/html
Back to TopTop